Is Franklin Biotechnology Discovery A (FBDIX) a Strong Mutual Fund Pick Right Now?
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 11 2024
0mins
Should l Buy ?
Source: NASDAQ.COM
Fund Overview: Franklin Biotechnology Discovery A (FBDIX) is a health sector mutual fund with a Zacks Mutual Fund Rank of 2 (Buy), offering a focus on the healthcare industry and has accumulated about $729 million in assets since its inception in 1997.
Performance and Costs: Despite delivering a 5-year annualized return of 7.85%, FBDIX ranks in the bottom third among peers; however, it has lower fees (1.04% expense ratio) compared to the category average, making it a potentially attractive option for investors looking for lower volatility and costs.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
